Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Stem Genomics logo — Next generation quality control for cell therapy

Stem Genomics

Next generation quality control for cell therapy

Founded 2018 France France 12 employees Biotechnology, Life Sciences +1

General Information

Company Name Stem Genomics
Founded Year 2018
Location France France +2
Employees 12
Industries Biotechnology, Life Sciences, Clean Energy
Social

Get notified when Stem Genomics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Stem Genomics

Stem Genomics is a biotechnology startup aiming to revolutionize the quality control for cell therapy with its flagship testing solution, iCS-digital™ PSC. Founded in 2018, the company specializes in assessing the genetic integrity of human stem cells, catering to research scientists by offering specific assays and recommended workflows tailored to their cell types. Stem Genomics' services cover a wide array of tests including G-Banding karyotyping, NGS analysis, mycoplasma detection, aneuploidy detection, as well as the ability to design customized assays to meet specific requirements. With a focus on biotechnology, life sciences, and clean energy, Stem Genomics leverages high precision, ease, and speed to provide essential genetic stability testing. The company's innovative approach that enables regular monitoring of stem cell lines in culture and screening large numbers of clones has the potential to significantly impact the field of cell therapy. As of now, there is no public information available regarding the last investment or the investors involved.

Taxonomy: Cell Therapy, Stem Cells, Genetic Integrity, Quality Control, Assay Development, Genomic Stability Testing, PSC Monitoring, Clonal Screening, NGS Analysis, Mycoplasma Detection, Aneuploidy Detection, Customized Assays, Digital PCR, Karyotyping, Research Services

No funding data available for Stem Genomics yet.

Get notified when Stem Genomics raises funding

Stem Genomics Alternatives & Competitors

Stem Genomics vs
ViruSure GmbH
ViruSure GmbH Austria

The specialists for virus safety testing!

49 employees
Biotechnology
Stem Genomics vs
Flow Contract Site Laboratory, LLC
Flow Contract Site Laboratory, LLC United States

Personalized Flow Cytometry Services

5 employees
Biotechnology, Health Care
Stem Genomics vs
Blitz Diagnostics
Blitz Diagnostics Switzerland

A PoC IVD platform for faster testing of inflections and diseases

2 employees
Health Care, Medical Devices
Also compare with: Stem Genomics vs PathoQuest PathoQuest

FAQ About Stem Genomics

Next generation quality control for cell therapy
Stem Genomics was founded in 2018.
Stem Genomics is headquartered in France.
Stem Genomics operates in the following industries: Biotechnology, Life Sciences, Clean Energy.
Stem Genomics has approximately 12 employees.
Top alternatives and competitors to Stem Genomics include ViruSure GmbH, Flow Contract Site Laboratory, LLC, Blitz Diagnostics, ImmunoChemistry Technologies, LLC, PathoQuest. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Stem Genomics and ViruSure GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Stem Genomics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy